Global HER-2 Negative Breast Cancer Market Share

Market Share of Global HER-2 Negative Breast Cancer Industry

The primary focus among the companies is to develop combination therapies that shall overcome the resistance of existing drug therapies in the market thus boosting the targeted disease treatment. This is done via collaboration and partnerships among the market players. Some major companies in this segment include AstraZeneca, Bristol-Myers Squibb Company (Celgene Corporation), Eli Lilly and Company, GSK plc., Merck & Co., Inc., Novartis AG, and Pfizer Inc.

HER-2 Negative Breast Cancer Market Leaders

1. Eli Lilly and Company

2. AstraZeneca

3. GSK

4. Novartis AG

5. Pfizer

*Disclaimer: Major Players sorted in no particular order